We provide a complete "going public" solution via a Reverse Public Offering ("RPO") as a growth financing alternative to traditional IPOs, late stage PE financings, or mezzanine financings. Our goal is to create substantial incremental shareholder value for emerging growth companies.
Generally there are two methods of RPO,
1) RTO+PIPE, the company would buy a "shell" company in OTCBB, gain first round of capital raising through a PIPE to expand its current business, and then transfer to a main board (NASDAQ Global Market, NASDAQ Capital market, NYSE AMEX, etc);
2) RTO to Main Board, the company would buy a "shell" company, and with professional services provided by Rx investment become a public-traded company directly listed on a main board (NASDAQ Global Market, NASDAQ Capital market, NYSE AMEX, etc).
RTO+PIPE is normally easier to operate and sets lower entry barrier for growth companies; RTO to Main Board process is usually shorter, but has higher requirement for preparation.
Rx Investment also provides advisory services to Chinese companies for their IPOs in the United States. U.S. IPOs typically take 10-18 months to complete, significantly faster than IPOs in mainland China.
We provide an integrated RPO solution for clients, including but not limited to:
· Deal Evaluation
Determine that the client has the necessary financial ingredients and management talents.
· Transaction Structuring
We recommend a deal plan (RTO+PIPE) that is most appropriate for the company at the time.
· Growth Capital Fundraise
We provide a roadmap for companies to migrate to NASDAQ through a series of stages.
· Transaction Management
Assist in handling clients’ negotiation of commerce all the way through each deal.
· Capital Market Strategies
We maintain relationships and a good network in the US capital market.
· After-market support
We stay active with our clients after the transaction. We support clients to investor conferences and require quality IR in all our deals.
· Follow on fundraise